ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

COG Cambridge Cognition Holdings Plc

48.00
-0.50 (-1.03%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cambridge Cognition Holdings Plc LSE:COG London Ordinary Share GB00B8DV9647 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -1.03% 48.00 47.00 49.00 48.50 48.00 48.50 53,426 10:40:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 12.61M -409k -0.0117 -41.03 16.73M
Cambridge Cognition Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker COG. The last closing price for Cambridge Cognition was 48.50p. Over the last year, Cambridge Cognition shares have traded in a share price range of 48.00p to 104.00p.

Cambridge Cognition currently has 34,852,833 shares in issue. The market capitalisation of Cambridge Cognition is £16.73 million. Cambridge Cognition has a price to earnings ratio (PE ratio) of -41.03.

Cambridge Cognition Share Discussion Threads

Showing 226 to 238 of 900 messages
Chat Pages: Latest  12  11  10  9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
20/9/2016
15:35
Don't see why they couldn't hang on until their figs on Thursday to announce this to the market. No hard numbers are mentioned after all. Bit sad really...
sspurt
20/9/2016
13:34
Good contract win for CANTAB Recruit
Doubled since placing and bb still quiet as a mouse.

phowdo
19/9/2016
14:35
GOLDEN CROSS beckons
10raygun
19/8/2016
19:57
i BOUGHT IN AT 88P and was dismayed to see share price fall. This is good news and I will be watching more closely
werewolfie
18/8/2016
12:35
Nice holding by Nigel Wray
hope67
17/8/2016
06:44
Cambridge Cognition Holdings (COG) 100% Buy
17th August 2016

dice1950
17/8/2016
05:20
The Daily Mail Cambridge Cognition Holdings (COG) rocketed 30 per cent



On the alternative market Cambridge Cognition climbed as it announced results from a study into the effectiveness of using gadgets to access brain health.
The neuroscience business said wearable technology such as the Apple Watch and Microsoft Band could be used to accurately measure cognitive performance in everyday life with its software.
Around 450million people across the world are living with some form of mental illness, the firm said, and the cost of treatment and care was likely to double by 2030.
Cambridge said its Cognition Kit software could help doctors and patients better understand and manage day-to-day brain health by measuring key factors in real time.
Participants in a study wore wearable technology which monitored their stress levels and physiological activity on a day-to-day basis and while they completed micro tests to measure attention, memory, mood and reaction speed. Shares rocketed 30 per cent, or 12p to 52.5p.

dice1950
16/8/2016
08:10
doing well since placing. Great statement today. Should be able to use that validation to monetise relationships going forward. well done to the new team!
maccamcd
02/6/2016
09:24
a good watch, panorama 8pm to-night
highlights the problems in coping
with dementia, diagnosis at 50yrs could mean his
disease may have started around the age 30/35yrs
50ml worldwide, 2ml in UK within ten yrs
the critical TIME factor is diagnosis to medication, cases of those coming off/given up on medication are known to reach stage 6 within just two/three months
shocking news on NHS with patient reviews after diagnosis
at one visit per year,

mike24
19/5/2016
18:12
Read Hybridan's note on CAMBRIDGE COGNITION HOLDINGS (COG), out this morning, by visiting hxxps://www.research-tree.com/company/GB00B8DV9647

"The specialist developer and distributor of computerised neuropsychological tests including those enabling the early detection of dementia, last month completed a placing raising gross proceeds of £1.25m. The company’s core customer base comprises leading academic research institutes and pharmaceutical and biotechnology companies. The development focus is now shifting to high volume measurement which will facilitate penetration into the healthcare market which is currently the company’s smallest revenue generator but..."

thomasthetank1
17/3/2016
12:05
Spotted this company yesterday after the fall, down again today I see, I may be tempted around 50p however the finances are a concern now, the fact that it is loss making is not surprising however cash is being eroded and a fundraising must be a possibility, has this company raised cash already since being listed ?? Thanks
eastbourne1982
16/3/2016
08:58
Having to look long term on this, especially after todays drop. Having seen the effects and cost due to not detecting early, development and implementation of this type of technology is vital. Early diagnosis is the key. However would like to forget the price I entered this share (no pun intended).
petes5
16/3/2016
08:56
Not doing a great job for shareholders though.
gargoyle2
Chat Pages: Latest  12  11  10  9  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock